BusinessMerck Raises 2026 Earnings Outlook After Keytruda Qlex Sales Beat EstimatesBy Helena WardOct 29, 2026, 1:16 PM UTC
HealthMerck Reports Longer Median Survival in Endometrial Cancer TrialBy Naomi CalderOct 26, 2026, 4:49 PM UTC
InvestingBiotech ETF Rises 23% as Drug Milestones Span Trials to ApprovalBy Celia RowanOct 24, 2026, 7:11 PM UTC
HealthINTerpath-001 Results Show 42% Lower Risk of Melanoma Recurrence or DeathBy Naomi CalderOct 24, 2026, 7:06 PM UTC
InvestingModerna Shares Fall 17.57% After Melanoma Trial Results Surface EarlyBy Celia RowanOct 23, 2026, 8:19 PM UTC
InvestingModerna Shares Fall 17.57%, Leaving Year-to-Date Gain at 587%By Celia RowanOct 22, 2026, 10:45 PM UTC
BusinessAgile Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment ConferenceBy Nasdaq OMXAug 22, 2017, 11:30 AM UTC
BusinessBiopharmaceutical Market Scope Rising With Escalating Health Concerns - IndustryARCBy Nasdaq OMXMar 28, 2017, 2:30 AM UTC
